1 / 20 Crushing virtual cigarettes helps reducing tobacco addiction. Final results from a preliminary control trial Girard 1, B., Turcotte 1, V., & Bouchard.

Slides:



Advertisements
Similar presentations
Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
Advertisements

Colorado Tobacco QuitLine David Tinkelman, MD. Tobaccos Toll In Colorado 17.9% of the states adult population smoke cigarettes This is approximately 626,000.
November, 2005 Iowa Department of Public Health. Tobacco Use in Iowa Approximately 4,600 tobacco- related deaths annually 20% of high school students.
Behavioral Health DATA BOOK A quarterly reference to community mental health and substance abuse services Fiscal Year 2011 Quarter 4 October 10, 2011.
Peter Tossmann Benjamin Jonas Marc Tensil Peter Lang Evelin Strüber Berlin / Cologne, June 2012 Quit the shit – An internet- based intervention program.
1 Workforce Retention in Supported Employment: Promising Practices Amy Gelb, MS, CAGS, CRC, CPRP- Rick Kugler, M.S., CPRP-
RANDOMIZED CONTROLLED TRIAL
2008 Johns Hopkins Bloomberg School of Public Health Setting Up a Smoking Cessation Clinic Sophia Chan PhD, MPH, RN, RSCN Department of Nursing Studies.
VERONICA CARDENAS, PH.D. UNIVERSITY OF CALIFORNIA, SAN DIEGO ELIZABETH LUGO & ROBERTO CERVANTES SAN YSIDRO HEALTH CLINIC, SAN DIEGO CONSUELO RAZO, R.N.
AAFP Office Champions Leading Tobacco Cessation in FQHCs
Results of a smoking cessation intervention programme in the workplace: lessons learnt Dr. Timea TOTH Ruzsas E, Biro B, Olajos A, Nikl A, Jelencsics Zs.
PROCESS vs. WA State SCS Study A Comparison of Study Design, Patient Population, and Outcomes August 29,2007.
Taking Medication Histories
13 Principles of Effective Addictions Treatment
1 Canada Research Chair in Health Education, Université du Québec à Montréal 2 Department of Sexology, Université du Québec à Montréal 3 Canada Research.
INDIVIDUAL VERSUS TECHNOLOGY Research, treatment and policy - ethical dilemmas Gabrielle Welle-Strand - Researcher, MD, Senior Adviser Pompidou Group –
Improving Women’s Health Prior to Pregnancy: A Key Strategy for Reducing Infant Mortality Presentation to the Improving Women’s Health Prior to Pregnancy:
Jean-François ETTER Evelyne LASZLO Jean-Pierre ZELLWEGER Charles PERROT Thomas PERNEGER University of Geneva, Switzerland Smoking reduction with NRT: a.
Helping pregnant smokers stop: intervention insights from LEAP Michael Ussher Professor of Behavioural Medicine St George’s, University of London.
A Virtual Arm to Stop Smoking A comparative study B. Girard 1, V. Turcotte 1 and S. Bouchard 2 1.GRAP, Occupational psychology clinic Saguenay (Québec)
Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore PRABHAKARAN.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Prevention strategies
Journal Club Alcohol and Health: Current Evidence May–June 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2009.
BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes and Smoking Cessation Sarah Boone, Carolyn Little, Clay Owens, Jeremy Randolph, Genny Tibbs.
The Ohio Partners for Smoke-Free Families 5A’s
First RCT of Web-Based Acceptance & Commitment Therapy For Smoking Cessation: 3 Month Processes & Outcomes Jonathan B. Bricker, PhD Fred Hutchinson Cancer.
Safety and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Addiction Tony Nguyen, PGY2.
Quittin’ Time: Helping Employees Become Tobacco-free June 2005.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Substance Use and Abuse Smoking. Smoking Tobacco: Who Smokes? Varies with age Gender differences Educational differences.
Journal Club Sidharth Bagga MD. Cytisus laborium L. (Golden rain acacia)
Smoking and Pregnancy: Status Profile 2007 Annie Berthiaume Roberta Heale Irene Koren Rachelle Arbour-Gagnon Funded by the Louise Picard Research Grant.
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Can undergoing an internet based ACT intervention change the impact of predictors thought to lead to Substance Use? Leonidou. G., Savvides. S., N. & Karekla.
OPIOID SUBSTITUTION THERAPY
A Virtual Arm to Stop Smoking A pilot perceptual learning experiment Benoît Girard and Vincent Turcotte GRAP, Occupational psychology clinic Saguenay (Québec)
THE IMPACT OF ANTI-DEPRESSANTS AND COGNITIVE THERAPY ON PANIC DISORDER Christopher Cannizzaro Rowan University Abnormal Psychology.
USING STANDARDIZED PATIENTS TO PILOT SCREENING VISITS IN CLINICAL TRIALS Lynn E. Kunkel, M.S., Holly Fussell, Ph.D., Colleen Shannon-Lewy, Ph.D., & Bentson.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Smokefree interventions in Emergency Care Are they working? Courtney Rouse Smokefree Specialist- Inpatient Services, MMH.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
“Comparing Two web-based Smoking Cessation Programs: Randomized- Controlled Trial” By: McKay et. Al.
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
E of computer-tailored S moking C essation A dvice in P rimary car E ffectiveness Hazel Gilbert, Irwin Nazareth and Richard Morris Department of Primary.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Hazelden Your Next Step Tobacco Recovery Program National Conference on Tobacco or Health Presented by Barry McMillen, MA, LADC, TAS.
****.. Models of Addictive Behaviour: To understand the biological, cognitive and learning models of addiction, including explanations for initiation,
Acute exercise effects on craving and withdrawal symptoms among women attempting to quit smoking using nicotine replacement therapy Dr. Therese Harper.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Tobacco treatment TrAining Network in Crete Tobacco treatment TrAining Network in Crete.
1 Should behavioural support for smoking cessation address wider psychological problems? University College London October 2013 Robert West.
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
Jonathan Foulds, Jessica M. Yingst, Susan Veldheer, Shari Hrabovsky,
Development and Implementation of a Tobacco Cessation Toolkit
Robert West University College London WCTOH Washington 2006
Robert West University College London London March 2008
Behavioural and pharmacological approaches to treating smokers
The Burden of Tobacco Use
ABCs of Behavioral Support
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Personalized prevention: mobile application for smokers
Tobacco Cessation for Primary Care Providers
Presentation transcript:

1 / 20 Crushing virtual cigarettes helps reducing tobacco addiction. Final results from a preliminary control trial Girard 1, B., Turcotte 1, V., & Bouchard 2, S. 1 GRAP, Occupational psychology clinic 2 Université du Québec en Outaouais

2 / 20 PILOT STUDY 2007 OBSERVATIONS: 1.Some clinical indications of modifying craving and smoking behaviours. 2.An action-cue exposure (ACET) strategy could be considered in the treatment of substance addiction.

3 / 20 Objective of the current study: –Test the advantages of adding to a psychosocial smoking cessation treatment program for adults four (4) sessions of immersion in virtual reality where the patient uses a virtual arm to crush cigarettes. Hypothesis: –Compared to the placebo condition, crushing virtual cigarettes will lead to: Better reduction in tobacco addiction Better abstinence Better retention in the program COMPARATIVE STUDY 2008

4 / 20 DESIGN 91 subjects randomly assigned Combined therapy (no medication):  psychosocial support + crushing virtual cigarettes  psychosocial support + grasping virtual balls No target quit date Study has been approved by the Research Ethics Board of UQO “Internal funding”

5 / 20 PRESELECTION (telephone) Recruitment through local medias Inclusion criteria : Age between 18 – 65 Daily smoking 10 cigarettes and more (last year) Fewer than 3 months abstinence (last year) Desire to stop smoking Exclusion criteria : Any serious or unstable disease (6 months) Treatment for major mental illness (last year) Use of medication to stop smoking (6 months) Regular use of CNS medication Treatment with “cybertherapy” (last year) History of severe substance abuse (last year) Pregnancy

6 / 20 SELECTION (clinic visit) Physical data : vital signs body mass index Smoking history :age duration number of attempts abstinence periods mean daily use Exhaled CO test Questionnaires VR adaptation session (10 min.) and tests Informed consent document Randomization

7 / 20 INTERVENTION (1) Psychosocial support Brief individual counselling (10-15 min) by a nurse : assist in problem solving, give information on withdrawal, analyse smoker’s journal. Smoking cessation self-help booklet : Guide to becoming a non smoker (Health Canada 2003). Exhaled CO test, vital signs and body mass index. Complete questionnaires. Frequency of visits : - weekly for 1 to 4th week - biweekly for 6th to 12th week Medical counselling (if necessary)

8 / 20 INTERVENTION (2) Immersion in virtual reality (all participants) Four weekly sessions : week 1 to 4th Time : 30 min. VR scenario, while exploring a castle either: –Grasping up to 50 virtual balls (placebo ctrl) –Crushing up to 50 virtual cigarettes Complete questionnaires Wait time after the immersion before leaving the office : min.

9 / 20 Pentium IV with nVidia 7300GS stereo video card eMagin z800 HMD Logitech wireless gamepad 3D work was integrated into a well-know game engine called Unreal 2™ from Unreal Tournament 2004™. XSI from Softimage was used for the virtual arm and environment’s creation EQUIPMENT

10 / 20 Video

11 / 20 Measures : (each visit at the clinic) Outcome Addiction: –Fagerström test for nicotine dependence (Heatherton, 1991) Smoking status: –Daily self report journal –Exhaled CO test (cut-off at 6 ppm). Drop out rate: –Stopping the program, no matter the reason… Process / side effects Presence Questionnaire (PQ; Witmer & Singer, 1998 ). Simulator Sickness Questionnaire (SSQ; Kennedy et al., 1993).

12 / 20 RESULTS Descriptive characteristics: n = 45 in the control condition (Balls) n = 46 in the experimental condition (Cigarettes) Average age: 44 years (SD = 11 years) Had been smoking for an 27 years (SD = 12 years). Gender: 57% female. Work status: 68% employed. Smoking frequency: 45 % smoked more than 21 cigarettes a day.

13 / 20 Results (intent-to-treat) Fagerström test ANOVA : Time [F(2,178) = 33.07, p <.001)] Interaction contrast : Condition [(F(1,89) = 4.69, p <.025] p <.01 at W4 / W12 Time/Condition interaction [F(2,178) = 3.75, p <.05]

14 / 20 Results (intent-to-treat) Abstinence (confirmed by CO test) χ 2 (1) = 1.84, ns χ 2 (1) = 4.79, p <.05 On a phone call 6-month post-Rx: Cigarettes: 39% abstinent Balls: 20 % abstinent

15 / 20 Retention rate in the program Number of patients in the program Weeks Balls Cigarettes Significantly more controls had dropped-out of treatment: at week 4 [22% vs 49%, χ2 (1) = 7.35, p <.001] at week 12 [50% vs 71%, χ2 (1) = 4.24, p <.05]. A significantly different retention profile [Gehan's Wilcoxon test (1) = 6.96, p <.01].

16 / 20 Process and side effects A multiple regression with PQ predicting change on the Fagerström was significant [F(2,90) = 39.78, p <.001] and showed that presence contributes significantly to changes in scores measuring tobacco addiction (sr 2 = -.18, p <.025). Cybersickness : [F (1,57) = 4.10, p <.05] Grasping virtual balls condition Mean (SD) Crushing virtual cigarettes condition Mean (SD) Week 1 Week 2 Week 3 Week (48.72) (42.45) (44.01) (41.47) (70.11) (55.57) (45.53) (62.55)

17 / 20 Conclusion Crushing virtual cigarettes had a significant effect on: –Fagerström (addiction) –Abstinence (confirmed by CO tests) –Drop-out (retention) Why ? –Staying longer in the treatment… Ok, but again, why? –Self-efficacy to crush burning cigarettes ? –Motivation to crush, to quit, enjoy crushing, stages of change ? –Practicing an automatic response ? Action cue exposure ? –New association with positive mood and smoking cessation ? Seeing cigarettes is no longer associated with frustration… More research is clearly needed …

18 / 20